Morgan Stanley’s Lombard Medical, Inc. EVAR Stock Holding History

Morgan Stanley’s Portfolio EVAR Stock Details EVAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-1,865	Closed	-$1K	–	6832
2017 Q3	$1K	Hold	1,865	–	–	﹤0.01%	6501
2017 Q2	$1K	Hold	1,865	–	–	﹤0.01%	6558
2017 Q1	$1K	Buy	1,865 +2	+0.1%	+$1	﹤0.01%	6539
2016 Q4	$1K	Hold	1,863	–	–	﹤0.01%	6491
2016 Q3	$2K	Hold	1,863	–	–	﹤0.01%	6394
2016 Q2	$2K	Sell	1,863 -28	-1%	-$39	﹤0.01%	6393
2016 Q1	$2K	Hold	1,891	–	–	﹤0.01%	6433
2015 Q4	$3K	Sell	1,891 -54	-3%	-$128	﹤0.01%	6481
2015 Q3	$7K	Sell	1,945 -571	-23%	-$2.19K	﹤0.01%	6339
2015 Q2	$11K	Buy	2,516 +1	+0%	+$5	﹤0.01%	6288
2015 Q1	$11K	Sell	2,515 -96,799	-97%	-$498K	﹤0.01%	6207
2014 Q4	$646K	Buy	99,314 +728	+0.7%	+$4.78K	﹤0.01%	4489
2014 Q3	$758K	Buy	98,586 +3,763	+4%	+$24.9K	﹤0.01%	4275
2014 Q2	$683K	Buy	+94,823	New	+$772K	﹤0.01%	4355

Other funds holding EVAR

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Morgan Stanley's EVAR Position: Q4 2017 in Review

Morgan Stanley sold out of Lombard Medical, Inc. (EVAR) in Q4 2017, closing a stake of 1,865 shares — an estimated $1K sold.

Morgan Stanley first reported a position in EVAR in Q2 2014 and held it in 14 quarters. The position peaked at $758K in Q3 2014. 2 funds tracked by Wall St. Rank hold EVAR as of Q4 2017.

Morgan Stanley reported no remaining Lombard Medical, Inc. position as of Q4 2017 after selling out during the quarter.
Morgan Stanley sold 1,865 Lombard Medical, Inc. shares in Q4 2017, an estimated $1K.
Morgan Stanley first reported a position in Lombard Medical, Inc. in Q2 2014 and held it in 14 quarters.
Morgan Stanley's Lombard Medical, Inc. position peaked at $758K in Q3 2014.
2 funds tracked by Wall St. Rank held Lombard Medical, Inc. as of Q4 2017.

Based on Morgan Stanley's 13F filing for Q4 2017, filed 14 Feb 2018.